SC 13D/A | 2019-04-26 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | - | 0.0% | EDGAR |
SC 13D | 2019-03-15 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | 1,894,657 | 4.9% | EDGAR |
SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | 1,850,375 | 4.8% | EDGAR |
SC 13G/A | 2019-02-14 | PERCEPTIVE ADVISORS LLC | OncoMed Pharmaceuticals Inc | 1,719,111 | 4.5% | EDGAR |
SC 13G | 2019-02-14 | HARBOURVEST PARTNERS LLC | OncoMed Pharmaceuticals Inc | 1,901,106 | 4.9% | EDGAR |
SC 13G/A | 2019-02-13 | Phase4 Partners Ltd | OncoMed Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
SC 13G/A | 2019-02-12 | DELPHI VENTURES VIII LP | OncoMed Pharmaceuticals Inc | 1,991,602 | 5.2% | EDGAR |
SC 13G/A | 2019-02-08 | PRIMECAP MANAGEMENT CO/CA/ | OncoMed Pharmaceuticals Inc | 5,506,300 | 14.2% | EDGAR |
SC 13G | 2018-12-21 | HARBOURVEST PARTNERS LLC | OncoMed Pharmaceuticals Inc | 1,941,098 | 5.0% | EDGAR |
SC 13D | 2018-12-17 | Mereo Biopharma Group plc | OncoMed Pharmaceuticals Inc | 4,130,907 | 10.7% | EDGAR |
SC 13G/A | 2018-02-27 | PRIMECAP MANAGEMENT CO/CA/ | OncoMed Pharmaceuticals Inc | 5,565,600 | 14.7% | EDGAR |
SC 13G/A | 2018-02-14 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | 2,049,592 | 5.4% | EDGAR |
SC 13G/A | 2018-02-14 | MORGENTHALER PARTNERS VII LP | OncoMed Pharmaceuticals Inc | - | 0.0% | EDGAR |
SC 13G/A | 2018-02-14 | PERCEPTIVE ADVISORS LLC | OncoMed Pharmaceuticals Inc | 2,620,897 | 6.9% | EDGAR |
SC 13G/A | 2018-02-13 | DELPHI VENTURES VIII LP | OncoMed Pharmaceuticals Inc | 1,991,602 | 5.3% | EDGAR |
SC 13G/A | 2018-01-31 | US VENTURE PARTNERS VIII L P | OncoMed Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
SC 13G | 2017-12-06 | PERCEPTIVE ADVISORS LLC | OncoMed Pharmaceuticals Inc | 2,470,897 | 6.5% | EDGAR |
SC 13G | 2017-06-06 | PRIMECAP MANAGEMENT CO/CA/ | OncoMed Pharmaceuticals Inc | 5,503,600 | 14.6% | EDGAR |
SC 13G/A | 2017-05-31 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | 1,843,484 | 4.9% | EDGAR |
SC 13G | 2017-04-27 | BIOTECHNOLOGY VALUE FUND L P | OncoMed Pharmaceuticals Inc | 1,372,923 | 3.6% | EDGAR |